Sarcoma & GIST
From the Journals
No staff COVID-19 diagnoses after plan at Chinese cancer center
Commentary
Perspective from the heartland: Cancer care and research during a public health crisis
Dr. Alan P. Lyss examines how the COVID-19 pandemic has and will affect cancer care and research.
Latest News
Cancer care and COVID-19 in Seattle, the first U.S. epicenter
Feature
How is oncology adapting to COVID-19?
Feature
Disruptions in cancer care in the era of COVID-19
Conference Coverage
Largest meeting on cancer research canceled: AACR
From the Journals
Late effects in young cancer survivors underscore importance of high-risk screening
Childhood cancer survivors have higher standardized mortality ratios than early-adolescent and young adult cancer survivors.
News
FDA: Cell phones still look safe
The available evidence does not suggest a causal link between cell phone use and cancer, according to the FDA.
From the Journals
CRISPR-engineered T cells may be safe for cancer, but do they work?
All three patients who received CRISPR-engineered T cells in a phase 1 trial experienced cancer progression but minimal toxicity.
From the Journals
Global project reveals cancer’s genomic playbook
The Pan-Cancer Analysis of Whole Genomes, an international collaboration, reveals the complexity of oncogenesis.
Article
Presentation of a Rare Malignancy: Leiomyosarcoma of the Prostate
Prostatic leiomyosarcoma is an aggressive malignancy with a high risk of metastasis and a poor prognosis that poses unique diagnostic and...